TVAX-008

N/A

Report date: 2026/03/16 20:01:47

Base Information

Drug NameTVAX-008
Drug Alias NameTVAX-008
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHBsAg inhibitorsToll like receptor 9 agonistsImmunostimulants
TargetsHepatitis B Surface AntigensToll like receptor 9
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesYuanda Weixin Life Science (Nanjing) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGrand Theravac Life Sciences (Nanjing) Co LtdYuanda Weixin Life Science (Nanjing) Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A